Dov A. Goldstein M.D., Director at Esperion Therapeutics, Inc. (ESPR), sold 1,600,000 shares at $43.48 ($66.7M) on 2017-03-21, disclosed to the SEC on 2017-03-23.
Open-market sale of $66.7M ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.48 | 487,358 | $21.2M | 31.8% |
| 2 | $43.48 | 487,358 | $21.2M | 31.8% |
| 3 | $38.82 | 312,642 | $12.1M | 18.2% |
| 4 | $38.82 | 312,642 | $12.1M | 18.2% |
| Total | $41.66 avg | 1,600,000 | $66.7M | 100% |
| Filing → |
| NBSE | BUY | 2021-04-27 | $60K | — | Filing → |
| NBSE | BUY | 2020-05-04 | $60K | — | Filing → |
| CEMP | SELL | 2017-03-09 | $533K | — | Filing → |